Lipodystrophy
back to main page
Lipodystrophy is a heterogeneous group of disorders characterized by abnormal distribution of adipose tissue in the body. The condition can lead to both the loss of adipose tissue (lipoatrophy) and its excessive accumulation in specific areas of the body. These disorders are of not only aesthetic but primarily metabolic significance, because adipose tissue functions as an active endocrine organ involved in the regulation of hormonal, insulin, and inflammatory balance. Lipodystrophy can be congenital or acquired, and its course often coexists with insulin resistance, type 2 diabetes, hypertriglyceridemia, and fatty liver. In clinical practice, it requires multidisciplinary diagnostics including dermatology, endocrinology, diabetology, and aesthetic medicine.
Lipodystrophy - what is it
Lipodystrophy means a qualitative or quantitative disorder of subcutaneous adipose tissue. Under physiological conditions, adipocytes, i.e. fat cells, store energy and secrete numerous cytokines and hormones, such as leptin or adiponectin. In the course of lipodystrophy, there is a loss of the normal function of these cells, which results in abnormal fat distribution and metabolic disorders.
The changes can affect the entire body or only selected anatomical areas. In some patients, an almost complete loss of adipose tissue of the limbs and trunk is observed, with simultaneous excessive fat deposition in the area of the neck, face, or abdominal cavity. A characteristic element of the disease is the fact that even lean individuals can present advanced metabolic disorders typical of visceral obesity.
Lipodystrophy is not only an aesthetic problem. Disorders of adipocyte function lead to ectopic fat deposition in internal organs, especially in the liver, muscles, and pancreas. The consequences may be:
- severe insulin resistance,
- diabetes,
- dyslipidemia,
- chronic inflammation,
- fatty liver,
- increased cardiovascular risk.
Modern diagnostics of lipodystrophy includes clinical assessment, hormonal tests, body composition analysis, and genetic diagnostics.
Lipodystrophy - what types does it have
The classification of lipodystrophy is based primarily on the extent of the changes and their etiology. Generalized and partial forms, as well as congenital and acquired forms, are distinguished.
Congenital lipodystrophy
Congenital forms most often result from genetic mutations affecting the development and function of adipocytes. Symptoms usually appear already in childhood. Patients present a very low level of adipose tissue with simultaneous strong muscularity of the physique. Metabolic disorders developing at a young age are also characteristic.
The most common types include:
- congenital generalized Berardinelli-Seip lipodystrophy,
- Dunnigan-type familial partial lipodystrophy,
- lipodystrophy syndromes associated with LMNA or PPARG mutations.
Acquired lipodystrophy
Acquired forms develop secondarily to other diseases or environmental factors. They may coexist with:
- autoimmune diseases,
- HIV infection,
- chronic inflammation,
- the use of certain medications,
- hormonal disorders.
A particular form is drug-induced lipodystrophy, previously observed in patients treated with HIV antiretroviral therapy. At that time, loss of facial and limb adipose tissue occurred with the simultaneous deposition of visceral fat.
Localized lipodystrophy
Localized loss of adipose tissue can occur after injuries, steroid injections, or chronic inflammation. Changes of this type are usually limited in nature and do not cause severe metabolic disorders, although they can be a significant aesthetic problem.
Lipodystrophy - causes
The etiology of lipodystrophy is complex and depends on the type of disorder. In the case of genetic forms, a key role is played by mutations of genes responsible for adipocyte differentiation, lipid storage, and cell membrane function.
The most important pathogenetic mechanisms include:
- disorders of fat cell maturation,
- triglyceride storage defects,
- chronic inflammation,
- autoimmune processes,
- mitochondrial dysfunction,
- hormonal disorders.
In acquired forms of the disease, the immune system plays an important role. In some patients, autoimmune destruction of adipocytes occurs. In other cases, lipodystrophy develops secondarily to the chronic use of drugs affecting lipid metabolism and insulin sensitivity.
Endocrine factors are also important. Disorders of the hormonal axis, particularly hyperinsulinemia and excess cortisol, can lead to abnormal distribution of adipose tissue. This phenomenon is observed, among other things, in Cushing's syndrome or advanced insulin resistance.
Modern research also points to the role of chronic oxidative stress and microcirculation disorders in the development of certain forms of lipodystrophy.
Lipodystrophy - symptoms
The clinical picture of lipodystrophy depends on the type of disease and the severity of metabolic disorders. The most characteristic symptom is abnormal distribution of adipose tissue.
Patients may observe:
- loss of adipose tissue in the limbs or face,
- excessive fat deposition in the abdominal area,
- hypertrophy of adipose tissue in the nape and neck,
- prominent visibility of muscles and veins,
- body asymmetry,
- difficulty in maintaining a normal body weight.
Aesthetic symptoms are often accompanied by metabolic disorders. Laboratory tests reveal:
- hypertriglyceridemia,
- elevated glucose levels,
- insulin resistance,
- decreased leptin levels,
- abnormal liver function tests.
Some patients develop organ complications, including:
- fatty liver,
- pancreatitis,
- hypertension,
- accelerated atherosclerosis,
- metabolic syndrome.
The psychological aspect also has a significant impact on the quality of life. Changes in body proportions and facial deformities often lead to reduced self-esteem, social withdrawal, and chronic emotional stress.
Lipodystrophy and other adipose tissue disorders
Condition | Characteristics |
|---|---|
Symmetrical hypertrophy of adipose tissue of the lower limbs with pain and swelling | |
Visceral obesity | Excessive accumulation of fat within the abdominal cavity |
Cellulite | Changes in the structure of subcutaneous tissue causing skin irregularities |
Lipoatrophy | Localized atrophy of adipose tissue |
Accumulation of lymph resulting from lymphatic system insufficiency |
It is particularly important to distinguish lipodystrophy from lipedema. In lipedema, adipose tissue undergoes painful hypertrophy mainly within the lower limbs, whereas in lipodystrophy, its atrophy or pathological redistribution associated with metabolic disorders dominates.
In the treatment of adipose tissue disorders, a multidirectional approach is used, including metabolic therapy, diet therapy, physical activity, and procedures supporting body remodeling. In aesthetic medicine and dermatology, technologies such as radiofrequency, acoustic waves, endermologie, treatments improving microcirculation, and procedures supporting the quality of the skin and subcutaneous tissue are used, among others.
The offer includes, among others, body shaping treatments, anti-cellulite therapies, lymphatic drainage, and procedures supporting the reduction of local adipose tissue disorders.
